Jazz Pharmaceuticals plc (Ireland) Stock Performance

Open $221.79	Prev. Close $222.28	Circuit Range N/A
Day Range $213.64 - $222.31	Year Range $128.90 - $266.28	Volume 84,098
Average Traded $219.18

Jazz Pharmaceuticals plc (Ireland) Share Price Today

As of 10 October 2026, Jazz Pharmaceuticals plc (Ireland)'s share price is $218.41. The stock opened at $221.79, compared to its previous close of $222.28. During today's trading session, Jazz Pharmaceuticals plc (Ireland)'s share price traded between $213.64 and $222.31, with an average price of $217.97. Over the past 52 weeks, the stock has recorded a high of $266.28 and a low of $128.90. In terms of performance, Jazz Pharmaceuticals plc (Ireland)'s share price has risen by 7.59% over the last six months and is up 58.71% on a year-on-year basis.

Jazz Pharmaceuticals plc (Ireland) Share Price Chart

$213.64$222.31

Jazz Pharmaceuticals plc (Ireland) Stock Fundamentals & Key Indicators

Market Cap $13.32B	PE Ratio (TTM) 15.35	Dividend Yield 0.00%
EPS (TTM) $14.49	Revenue (TTM) $4.27T	Return On Equity (TTM) 19.59%
Profit Margin -8.35%	Debt to Equity 0.91	Quarterly Earnings Growth YoY -23.31%

Jazz Pharmaceuticals plc (Ireland) Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$1126.11	$1197.93	$1068.90	$1208.30
Net Profit	$251.41	$203.45	$293.10	$192.80
Net Profit Margin	22.33%	16.98%	27.42%	15.96%
Income Change	N/A	-19.08%	44.06%	-34.22%

Jazz Pharmaceuticals plc (Ireland) Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$3659.37	$3834.20	$4068.95	$4267.59
Net Profit	-$224.06	$414.83	$560.12	-$356.15
Net Profit Margin	-6.12%	10.82%	13.77%	-8.35%
Income Change	N/A	285.14%	35.02%	-163.58%

About Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals plc (Ireland) Historical Returns

Month	Open	Close	Change %
Oct 2026	$230.99	$218.51	-5.70%
Sep 2026	$252.50	$231.72	-7.66%
Aug 2026	$253.13	$250.94	-0.63%
Jul 2026	$239.57	$252.54	+4.80%
Jun 2026	$235.50	$240.98	+1.82%
May 2026	$203.54	$236.68	+16.59%
Apr 2026	$190.13	$203.01	+7.53%
Mar 2026	$187.93	$188.79	-0.61%
Feb 2026	$165.48	$189.94	+15.45%
Jan 2026	$170.01	$164.52	-3.23%
Dec 2025	$174.76	$170.01	-3.78%
Nov 2025	$137.24	$176.68	+28.38%

JAZZ Share Price FAQs

What is Jazz Pharmaceuticals plc (Ireland) share price today?

Jazz Pharmaceuticals plc (Ireland) share price today is $218.41 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Jazz Pharmaceuticals plc (Ireland) stock?

The 52 week high of Jazz Pharmaceuticals plc (Ireland) stock is $266.28, while the 52 week low is $128.90 as of 10 Oct '26.

What is JAZZ's market capitalisation today?

JAZZ market capitalisation is $13.32B as of October 10, 2026, at 3:00 am IST.

What is JAZZ's net income for the last quarter?

JAZZ's net income for the last quarter is 192.80B USD.

What is the 5 year returns of JAZZ?

The 5 year returns of JAZZ is 64.17% as on 10 Oct '26.

What is the high & low stock price of JAZZ today?

JAZZ stock price hit a high of $222.31 and low of $213.64 as of 10 Oct '26.

Can I buy JAZZ shares in India?

Yes. You can buy JAZZ in India by opening an international trading account.